We describe two rare cardiac findings on baseline FDG PET in histologically proven aggressive large B-cell non-Hodgkin's lymphoma (NHL).
We describe two rare cardiac findings on baseline FDG PET in histologically proven aggressive large B-cell non-Hodgkin's lymphoma (NHL).
The first case is a 21-year-old woman with stage IV NHL with a superior mediastinal mass and two lung nodules on contrast-enhanced CT images. FDG PET/CT showed intense uptake in these lesions and, without contiguity, a round pathological cardiac uptake in the apical septum and the right ventricle (a, b FDG PET images; c, d fusion FDG PET/CT images; transverse and sagittal, respectively). The electrocardiogram showed negative T-waves in the septal location with left chest pain and dyspnoea. Transthoracic echocardiography confirmed the presence of a 3-cm mass near the apex with development towards the right and left ventricles, without thrombus or pericardial effusion. Cardiac MR imaging revealed a hyperintense aspect on T2-weighted sequences, isointense on T1 sequences (e cine sequence T2-/T1-weighted image; f short-axis T2-weigted black blood SPIR image). This mass had disappeared on FDG PET/CT and echocardiography performed after two and four cycles of chemotherapy.
The second case is a 51-year-old man with stage III NHL on CT imaging who underwent FDG PET/CT revealing posterior parietal right auricular involvement (g transverse FDG PET image; h fusion FDG PET/CT image), confirmed on MR imaging (i T1-weighted SE image, black blood, four chambers view). The FDG PET/CT scan at the end of treatment was normal.
Metastases to the heart and pericardium are rare [1] in NHL but are associated with a poor prognosis, and are usually revealed by cardiac complications [2] . In these cases, FDG PET allowed early diagnosis and earlier chemotherapy, leading to the disappearance of cardiac locations before the occurrence of any cardiac complications, and therefore improving survival.
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